Ionis Pharmaceuticals Inc
IONS
$43.67-3.56%
End of day · as of Oct 13, 2026, 8:00 AM ET
Mkt cap
$12.28B
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$267.95M
EPS (TTM)
$-1.35
Gross Margin (qtr ended 2026-06-30)
98.98%
Profit Margin (qtr ended 2026-06-30)
-42.79%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported IONS revenue for 2026-06-30 was $267.9M. Net income was -$114.6M. Revenue was up 8.9% from 2026-03-31 to 2026-06-30. IONS currently screens at market cap $12.28B.
Use this IONS research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full IONS income, balance, and cash tables.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company in the Healthcare sector.
Latest cached Ionis Pharmaceuticals Inc (IONS) revenue for Jun 30, 2026 was $267.9M. Net income was -$114.6M. Statements: https://lician.com/financials/ions
Ionis Pharmaceuticals Inc (IONS) market capitalization is $12.28B on the latest cached snapshot.
Ionis Pharmaceuticals Inc (IONS) cached previous close $45.28; day range $43.67 – $45.46; volume 1,891,015. Session quote: https://lician.com/quote/ions
Ionis Pharmaceuticals Inc (IONS) latest cached earnings event is "IONS earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IONS filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/ions